Image

Self-Myofascial Release of the Upper Cervical Muscles

Self-Myofascial Release of the Upper Cervical Muscles

Recruiting
19 years and older
All
Phase N/A

Powered by AI

Overview

The primary objective is to examine the influence of the suboccipital muscles on the superficial back line. The investigators will measure the following as part of this objective:

  • Changes in biomechanical and viscoelastic properties of points within the superficial back fascial train measured by a handheld myotonometer.
  • Pain pressure threshold measured by algometry.
  • Ankle range of motion.
  • Foot plantar pressure changes.

All participants will have a 5-minute self-myofascial release intervention.

Description

The superficial back line is a network myofascial segments that are connected and extend from the plantar foot up through the posterior lower extremity and back, up to the head. These connective tissue and muscular tracks play a role in supporting upright stance and motion. Dysfunction in one segment of the superficial back line can manifest as pain in a different segment of the fascial system. For example, hamstring and gastrocnemius muscle tightness have been associated with altered foot biomechanics and pain. The suboccipital muscles play an important role in head and body posture; therefore, they can influence eye positioning as it relates to head movements and perturbations. Because of this, the suboccipital muscles may have a hierarchical control over the SBFL. Dysfunction in the suboccipital muscles may exert more widespread effects on muscles and tissues at distant regions of the SBFL. Studies have shown that neck pain and forward head posture are associated with altered gait and ankle posture respectively. In addition, stress, anxiety, and poor sleep quality are associated with increased pain sensitivity and disability. How the interconnectedness of the SBFL responds to treatment is not fully understood. Proper treatment of musculoskeletal pain requires a better understanding of the function of myofascial connections and how dysfunction in one segment affects other regions. Also, enhanced understanding of the influence of stress, anxiety, and low sleep quality on response to treatment is needed. This understanding will better inform clinical practice and support the need for a more holistic approach to treating musculoskeletal pain.

The primary objective is to examine the influence of the suboccipital muscles on the superficial back line. Specifically, investigators will measure the following as part of this objective:

  • Changes in biomechanical and viscoelastic properties of points within the superficial back fascial train measured by a handheld myotonometer.
  • Pain pressure threshold measured by algometry.
  • Ankle range of motion.
  • Foot plantar pressure changes.

A secondary objective is to demonstrate a relationship between changes within the SBFL and stress, anxiety, sleep quality and non-debilitating pain. To achieve this secondary objective, the investigators will use the following:

  • Perceived Stress Scale-10 (PSS-10)
  • General Anxiety Disorder-7 (GAD-7)
  • Pittsburgh Sleep Quality Index (PSQI)
  • Numerical Rating Scale (NRS) will be utilized to record participants' intensity, frequency, and duration of non-debilitating lower extremity pain and back pain.

Eligibility

Inclusion Criteria:

• Adults 19 years of age and older from VCOM-Auburn and the Auburn area.

Exclusion Criteria:

  • pain that alters gait and/or limits/alters normal daily function
  • currently undergoing treatment by a healthcare provider
  • loss of function
  • use of prescription drugs for muscle or muscle relaxants
  • Pregnancy (hormonal changes affecting tissues could be a confounding variable)
  • inflammatory arthritis and fibromyalgia
  • diabetes or prediabetes
  • lumbar radiculopathy or disc pathology
  • previous surgery of the spine or lower extremity
  • injury to the lower extremity within the past 6 months
  • neurological or musculoskeletal diseases
  • cancer or blood disorder
  • current tobacco use
  • other conditions that alter gait

Study details
    Suboccipital Muscles
    Superficial Back Line
    Myofascial Release

NCT06529991

Edward Via Virginia College of Osteopathic Medicine

15 August 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.